Other

Preferred Stock, Shares Authorized

Boston Scientific Preferred Stock, Shares Authorized remained flat by 0.0% to 50M in Q3 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from 50M to 50M. Over 4 years (FY 2020 to FY 2024), Preferred Stock, Shares Authorized shows relatively stable performance with a 0.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: other_preferred_stock_shares_authorized

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value50M50M50M50M50M50M50M50M50M50M50M50M50M50M50M50M50M50M
QoQ Change+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%
YoY Change+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%
Range50M50M
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak17+ quarters growth

Frequently Asked Questions

What is Boston Scientific's preferred stock, shares authorized?
Boston Scientific (BSX) reported preferred stock, shares authorized of 50M in Q3 2025.
How has Boston Scientific's preferred stock, shares authorized changed year-over-year?
Boston Scientific's preferred stock, shares authorized decreased by 0.0% year-over-year, from 50M to 50M.
What is the long-term trend for Boston Scientific's preferred stock, shares authorized?
Over 4 years (2020 to 2024), Boston Scientific's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from 50M to 50M.